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In recent years, numerous studies have demonstrated the health beneﬁts of polyphenols. A major portion
of polyphenols in western diet are derived from coffee, which is one of the most consumed beverages in
the world.
It has been shown that many polyphenols gain their beneﬁcial properties (e.g. cancer prevention)
through the activation of the Nrf2/Keap1 pathway as well as their direct antioxidant activity. However,
activation of Nrf2 in cancer cells might lead to resistance towards therapy through induction of phase II
enzymes.
In the present work we hypothesize that caffeic acid (CA), a coffee polyphenol, might act as an
electrophile in addition to its nucleophilic properties and is capable of inducing the Nrf2/EpRE pathway
in cancer cells.
The results indicate that CA induces Nrf2 translocation into the nucleus and consequently its tran-
scription. It has been demonstrated that generated hydrogen peroxide is involved in the induction
process. It has also been found that this process is induced predominantly via the double bond in CA
(Michael acceptor). However, surprisingly the presence of both nucleophilic and electrophilic moieties in
CA resulted in a synergetic activation of Nrf2 and phase II enzymes.
We also found that CA possesses a dual activity, although inducing GSTP1 and GSR, it inhibiting their
enzymatic activity.
In conclusion, the mechanism of induction of Nrf2 pathway and phase II enzymes by CA has been
elucidated. The electrophilic moiety in CA is essential for the oxidation of the Keap1 protein. It should be
noted that while the nucleophilic moiety (the catechol/quinone moiety) can provide scavenging ability, it
cannot contribute directly to Nrf2 induction. It was found that this process may be induced by H2O2
produced by the catechol group.
On the whole, it appears that CA might play a major role in the cancer cells by enhancing their
resistance to treatment.
& 2014 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/3.0/).Introduction
Coffee is one of the most popular and consumed beverages in
the world. A solid epidemiological data show that daily coffee
consumption is associated with a decreasing risk for many types of
cancers [1–4]. The risk for type II diabetes is also decreased by
daily coffee consumption [5]. These properties may be attributedB.V. This is an open access article
acid; DMCA, dimethylcaffeic
elch ECH associating protein
ione; GST, glutathione-S-
xygenase 1; NQO1, NAD(P)H
chool of Pharmacy, Faculty of
rael.to high polyphenol content of coffee as it considered a major
source of polyphenol intake in the western diet.
Polyphenols are a group of phytochemicals that are found in
many foods. Today about 8000 compounds are identiﬁed, most of
them natural antioxidants [6,7]. Besides their antioxidant activity,
many polyphenols have other beneﬁcial health properties such as
antibacterial [8,9], anti inﬂammatory [10,11] and cancer pre-
ventive [12,13]. We showed in a previous work that coffee poly-
phenols act as antioxidants in the GI tract [14].
Coffee is rich with polyphenols originating from the hydro-
cinnamic family, mainly chlorogenic and caffeic acids [15]. The
best known component of coffee, caffeine, constitutes only 1–2.5%
of dry coffee beans, while polyphenols can reach 10% and more of
coffee dry weight [16]. Most of the chlorogenic acids are meta-
bolized in the colon to free caffeic or ferulic acids [17].
Many polyphenols, such as curcumin, epigallocatechin gallateunder the CC BY license (http://creativecommons.org/licenses/by/3.0/).
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ﬁcial properties through the activation of the Nrf2/Keap1 pathway
[18–20].
Under normal conditions, Nrf2 is targeted by Keap1, which
promotes Nrf2 proteasomal degradation via interactions with
ubiquitin ligase. Keap1 further functions as a sensor of stress sig-
nals, through stress-induced oxidation of key cysteine residues
that lead to conformational changes which promotes Nrf2 release
from Nrf2/Keap1 complex and translocation of the former to the
nucleus. In the nucleus Nrf2 interacts with basic leucine zipper
transcription factors such as Maf and Jun family members and
binds to a cis-acting element, the electrophile response element
(EpRE or antioxidant response element-ARE) [21]. Nrf2–EpRE is a
major pathway which regulate phase II antioxidant responses,
stress responses and cell proliferation. EpRE inducers consist of
several types of chemicals, including (1) redox-active bisphenols,
quinones, and phenylenediamines; (2) Michael acceptors; (3) iso-
thiocyanates; (4) dimercaptans; (5) hydroperoxides; (6) metals;
(7) polyphenols and more [22].
Nrf2 is found to induce phase II cytoprotective genes related to
cellular stress response, such as the heme oxygenase 1 (HO-1),
ferritin, NAD(P)H quinone oxidoreductase (NQO1), thioredoxin and
glutathione metabolizing genes such as: glutathione s-transferases
(GSTs), γ-glutamyl transpeptidase (GGT), GSR, GPx and glutamyl
cysteine ligase (GCL) [23].
Nrf2 activation is considered nowadays as a double edged
sword. On one hand, Nrf2 plays an essential role in maintaining
cellular homeostasis and hence represents a critical target for
prevention of oxidative stress or inﬂammation associated carci-
nogenesis [24]. On the other hand, over expression or higher ratio
of nuclear/cytosolic Nrf2 may give advantage to cancer cells in
coping with various cytotoxic drugs via the expression of phase II
detoxifying enzymes [25]. For example, tumors over expressing
GSTP1 are found to be in high correlation with tumor resistance
towards cisplatin treatment [26].
The GSTs are a multigene family of isoenzymes involved in the
detoxiﬁcation of endogenous as well as exogenous substances
such as chemotherapeutic drugs by conjugation of GSH to the
electrophilic site of the substance [27]. GST has been shown to be
overexpressed in various human cancer tissues made resistant to
chemotherapeutic drugs [28,29]. Hence, activation of Nrf2 in
cancer cells might lead to resistance towards radiation and che-
motherapy through induction of phase II enzymes. Coffee, there-
fore, may be cancer preventive but it might reduce the efﬁciency
of chemotherapy through phase II gene induction during treat-
ment of the ongoing disease.
Caffeic acid (CA) possesses both nucleophilic (catechol) moiety
and electrophilic (Michael acceptor) moiety. It is believed that
polyphenols induce Nrf2 not in their nucleophilic form, but rather
in the oxidized form (quinone) after electron/s donation. H2O2 isFig. 1. Structures and chemical properties of CA andgenerated during the oxidation of polyphenols in aqueous media
in the presence of oxygen [30]. H2O2 is a known inducer of Nrf2,
and thus it is possible that polyphenols induce Nrf2 only, in-
directly, via H2O2 [31]. In order to understand which group of CA is
responsible for Nrf2 induction we chose two CA derivatives: di-
hydrocaffeic acid (HCA) which consists of the polyphenolic group
only and dimethylcaffeic acid (DMCA) consisting of only the Mi-
chael acceptor group (Fig. 1). In the present work we hypothesize
that caffeic acid (CA), might act as an electrophile in addition to its
nucleophilic properties and is capable of inducing the Nrf2/EpRE
pathway in cancer cells. We also set to reveal the differences of
phase II gene induction and activities in different cells, thus we
chose 2 cell lines: ovarian carcinoma cells, A2780 and cisplatin
resistant daughter cell line, A2780cisR. These ﬁndings may provide
us with further understanding of the structure–activity relation of
Nrf2 induction by polyphenols and the beneﬁcial or harming
properties of coffee consumption during cancer treatment.Materials and methods
Materials
Caffeic acid (CA), 3,4-dihydrocinnamic acid (HCA), 3,4-di-
methoxycinnamic acid (DMCA), 1-chloro-2,4-dinitrobenzene
(CDNB), reduced glutathione (GSH), oxidized glutathione (GSSG),
gly–gly, L-γ-glutamyl-p-nitronilide, NADPH, ATP, cysteine, gluta-
mine, serine, 2,3 naphthalene dicarboxaldehyde (NDA), 5-sulfo-
salicylic acid (SSA), 3-(4,5-dimethylthiazole-2-yl)-2,5-diphenyl
tetrazolium bromide (MTT), enzymes and other common reagents
were purchased from Sigma Chemical Co., St. Louis, MO. Primary
and secondary antibodies were purchased from Abcam, Cam-
bridge, MA. RNA isolation kits, cDNA kits and qRT-PCR reagents
were purchased from Agentek, Israel.
Cell culture
Human ovarian carcinoma cells A2780 and the daughter line
A2780cisR were obtained from ATCC, USA. The cells were cultured
in RPMI 1640 medium supplemented with 10% fetal bovine serum,
2 mM L-glutamine, and 50 mg/ml gentamycin. The cultures were
maintained in a humidiﬁed 5% CO2 incubator at 37 °C. Cells were
subcultured every 3–4 days to maintain logarithmic growth and
were allowed to grow for 24 h before use.
RT-PCR
2105 Cells were seeded per well in 6 wells dish to examine the
effect of the test compounds on the transcription of Nrf2 and other
phase II genes. All compounds were dissolved in PBS. Followingits derivatives, HCA and DMCA (left to right).
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rapidly rinsed with ice-cold PBS. Total RNA was extracted with TRI
Reagent (Sigma). 1 Microgram of RNA was reverse transcribed at
37 °C for 120 min using primers as described below using Omnis-
cript Reverse Transcription Kit (QIAGEN). cDNA obtained from the
reverse transcriptase (RT) reaction (amount corresponding to 1 mg
of total RNA) was subjected to PCR using QuantiTect SYBR Green
PCR (QIAGEN). PCR reaction parameters were as follows: heating to
50 °C for 2 min, incubation at 95 °C for 10 min and thereafter 40
cycles of denaturation at 94 °C for 15 s, annealing at 60 °C for 60 s
and extension at 72 °C for 30 s. This relative quantiﬁcation com-
pares the PCR signal of the target transcript to the endogenous
control gene GAPDH. Primers: Nrf2 forward 5′-ATT TCT CCC AAT
TCA GCC AGC CCA-3′ Nrf2 reverse 5′-TAC AAA CGG GAA TGT CTG
CGC CAA-3′ HO-1 forward 5′-GGC AGA GAA TGC TGA GTT CAT GAG
GA-3′ HO-1 reverse 5′-ATA GAT GTG GTA CAG GGA GGC CAT CA-3′
GAPDH forward 5′-TCG ACA GTC AGC CGC ATC TTC TTT-3′ GAPDH
reverse 5′-ACC AAA TCC GTT GAC TCC GAC CTT-3′ GSTP1 forward 5′-
GGC TAG GAC CTC ATG GAT CA-3′ GSTP1 reverse 5′-ACC TCC GCT
GCA AAT ACA TC -3′ NQO1 forward 5′-AAG CCG CAG ACC TTG TGA
TAT TCC-3′ NQO1 reverse 5′-AAC ACT CGC TCA AAC CAG CCT TTC-3′
GCLM forward 5′-ACA GCT GTT GAC TCA CAA TGA TCC-3′ GCLM
reverse 5′-GTG CGC TTG AAT GTC AGG AAT GCT-3′ GSR1 forward 5′-
GCC GCC TGA ATG CCA TCT ATC AAA-3′ GSR1 reverse 5′-TAT TGT
GGG CTT GGG ATC ACT CGT-3′.Immunochemical staining
Cells were seeded on sterilized cover slips 24 h prior to treat-
ments. Following treatments the cover slips were washed 4 times
with 0.05% Tween in PBS and ﬁxed with 4% formaldehyde in PBS
for 10 min and washed twice with cold PBS. For permeabilization,
cells were incubated in 0.25% Triton X-100 for 10 min. Cells were
blocked by 10% goat serum in PBST containing 0.3 M glycine for
30 min.
Cells were then incubated overnight at 4 °C with primary rab-
bit-antihuman Nrf2 antibody (Abcam, Cambridge, Massachusetts)
diluted according to manufacturer's instructions. Cells were wa-
shed with PBS 35 min and incubated with secondary FITC-goat
antirabbit antibody (Abcam, Cambridge, Massachusetts, USA) for
1 h at RT in the dark, washed and counterstained with 0.5 mg/ml
Hoechst33258 (Abcam, Cambridge, Massachusetts, USA) for
10 min in the dark. The slips were mounted and read on FluoView
FV10i confocal microscope (Olympus, Hamburg, Germany). The
nucleus/cytosol ratio was calculated using ImageJ software by di-
viding FITC intensity in the nuclei area by FITC intensity in the
cytosol area of at least 5 cells in each slip, 6 slips for each
treatment.Western blotting
Protein expression in A2780 and A2780cisR cells was analyzed
as described previously [32]. The proteins were extracted in de-
naturation buffer (Tris pH 6.8, 20% SDS, glycerol and mercap-
toethanol) and separated on 13% acrylamide gel. The primary an-
tibodies were purchased as follow: GCLM, GSR, GST3/GSTP, β-tub
(Rabbit monoclonal Abcam, Cambridge, Massachusetts, USA). β
Tubulin was used as loading control.
Primary antibodies were detected using a horseradish perox-
idase-conjugated antibody and enhanced chemiluminescence
(Abcam, Cambridge, Massachusetts, USA). The ﬁlms were scanned,
and band intensity was quantiﬁed using densitometry software
(ImageJ, National Institutes of Health, Bethesda, Maryland, USA).Enzyme activity assays
The cells were washed following the treatments with ice-cold
PBS and then homogenized with 0.5 ml cold homogenization
buffer (50 mM potassium phosphate pH 7.4, 1.15% KCl). The
homogenates were frozen overnight at 80 °C, sonicated (3 cycles of
10 s with 5 s intervals) and centrifuged at 10,000g for 20 min at
4 °C. Protein content was measured by the method of Bradford
et al. [33] using bovine serum albumin as a standard.
GST activity, expressed as % of control, was determined ac-
cording to Habig et al. [34]. The assay was performed using po-
tassium phosphate buffer (pH 6.5) with reduced glutathione (GSH)
and 1-chloro-2,4-dinitrobenzene. Activity was calculated from the
changes in absorbance at 340 nm (ε340 nm¼9.6 mM1 cm1).
GSR activity was determined according to the method de-
scribed by Beutler et al. [35]. The assay was performed using
0.5 mM EDTA, 0.10 M sodium phosphate buffer (pH 7.6) with
oxidized GSH and NADPH. Activity was calculated from the
changes in absorbance at 340 nm (ε340 nm¼6.22 mM1cm1).
GCL activity was determined according to the method de-
scribed by White et al. [36]. GCL reaction cocktail (400 mM Tris,
40 mM ATP, 20 mM L-glutamic acid, 2.0 mM EDTA, 20 mM sodium
borate, 2 mM serine, 40 mM MgCl2) were pipetted into wells. The
GCL reaction was initiated by adding cysteine (dissolved in TES/SB)
to each GCL activity well (cysteine was not added to the GSH-
baseline wells at this time). The plate was then vortexed, covered,
and incubated for 30 min. The GCL reaction was terminated by
adding SSA to all wells, and then 2 mM cysteine was added to the
GSH-baseline wells. The plate was then vortexed and held on ice
for 20 min. Following protein precipitation, the plate was cen-
trifuged for 5 min at 2500 rpm on an Eppendorf centrifuge. Fol-
lowing centrifugation, aliquots of supernatant from each well of
the reaction plate were transferred to a 96-well plate designed for
ﬂuorescence detection. Next, NDA derivatization solution (50 mM
Tris, pH 10, 0.5 N NaOH, and 10 mM NDA in DMSO, v/v/v 1.4/0.2/
0.2) was added to all wells of this plate. The plate was covered to
protect the wells from light and allowed to incubate at room
temperature for 30 min. Following incubation, ﬂuorescence in-
tensity was measured (472 ex/528 em) on a ﬂuorescence plate
reader (Bio-Tek synergy HT plate reader).
DCF assay
Cells were seeded in 96 well plates in 100% conﬂuence. In
darkness, 100 mM of H2DCF in fresh cell medium added for 30 min
at 37 °C. The cells were washed twice with PBS then treated for
30 min (including tBHP standards for calibration). The cells were
washed again 3 times and 0.1 ml of DMSO:PBS (9:1) was added
and the plates were shaken at RT for 10 min. Plates were measured
(exs. 485–490/em 520–530) on a ﬂuorescence plate reader (Bio-
Tek synergy HT plate reader). The results presented as % of control
(normalized arbitrary ﬂuorescence units).
Anoxic experiments
Cells were seeded on 6 well plates for 24 h prior to the ex-
periment in a humidiﬁed 5% CO2 incubator at 37 °C. Then the cells
were treated and transferred to an ischemia chamber as previously
described by Portugal-Cohen et al. [37]. Briefly, the chamber was
saturated with 95% N2–5% CO2, oxygen levels were monitored the
entire time (0.7–1 mg/l) and the systemwas heated to 37 °C by hot
water circulation. Incubation period was 6 h.
Statistical analysis
The results are expressed as means7S.E. and were analyzed
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Dunnett’s t-test. P values less than 0.05 were considered statisti-
cally signiﬁcant. All analyses were conducted using Stat version
3.01 (Graph Pad Inc.).Results
Nrf2 translocation
In order to ﬁnd out whether CA can imitate the Nrf2/Keap1
pathway, we ﬁrst examined its ability to induce translocation ofFig. 2. Effect of CA on Nrf2 translocation in A2780 cells. The ﬁgure is a representative (n
and for nuclei (Hoescht-blue). The cells were either untreated (panel A) or incubated with
an atmosphere of 5% (v/v) CO2. (b) Ratio between cytoplasmic and nuclear Nrf2 measured
vs. control. All pictures are in the same scale.the Nrf2 protein into the nucleus. It is known that the ratio of
nucleic/cytosolic Nrf2 is important for the phase II genes
transcription.
A2780 cells were measured in ﬂuorescence microscope fol-
lowing their staining with FITC ﬂuorescent dye for Nrf2 and
Hoechst 33258 dye for the nuclei (Fig. 2a). Fig. 2b shows that in the
control cells Nrf2 is located both in the nucleus and in the cytosol
with cyt/nuc ratio of 1.37. Following treatment with 50 mM of CA,
Nrf2 is translocated into the nucleus and the ratio is signiﬁcantly
reduced to 1.11. Trigonelline, an alkaloid known for its inhibitory
effect on Nrf2 translocation [38] prevented the translocation of
NRf2 induced by CA. It can be seen that at 1 mM trigonelline, most¼ 6) result for confocal laser-scanning. (a) A2780 cells stained for Nrf2 (FITC-green)
50 mM CA (panel B), 1 mM trigonelline (panel C) or both (panel D) for 6 h at 37 °C in
by color analysis (Fluoview1 software, Olympus, Hamburg, Germany). p¼0.003 CA
a b
c d
e f
Fig. 3. Effects of CA (black), DMCA (white) and HCA (gray) treatments on Nrf2 and phase II mRNA levels in A2780/cisR cells. (a) Effects of CA, DMCA and HCA treatments on
Nrf2 mRNA levels; (b) effects of CA, DMCA and HCA treatments on GSTP1 mRNA levels; (c) effects of CA, DMCA and HCA treatments on GSR1 mRNA levels; (d) effects of CA,
DMCA and HCA treatments on GCLM mRNA levels; (e) effects of CA, DMCA and HCA treatments on HO-1 mRNA levels; (f) basal mRNA levels of untreated cells. Data are
expressed as n-fold of control (untreated cells) normalized to GAPDH 7SD of 6 independent experiments each conducted in triplicate, npo0.05; nnpo0.005.
R. Sirota et al. / Redox Biology 4 (2015) 48–5952of the Nrf2 remained in the cytosol at a ratio of 1.33. Combination
of CA and trigonelline showed results similar to the control.
Nrf2 and phase II genes expression in A2780/cisR cells following CA,
HCA, and DMCA treatment
Nrf2, GSH metabolizing enzymes and other phase II gene ex-
pressions were assessed by qRT-PCR. In A2780 cells, Nrf2 mRNA
level was induced to a 2-fold expression following treatment withCA and DMCA. However, as shown in Fig. 3a, HCA was unable to
induce expression of the Nrf2 mRNA. In the A2780cisR cells, the
basal level of Nrf2 was twice as high as the sensitive cells (Fig. 3f).
It can also be seen that those cells are much more susceptible for
induction by CA. The Nrf2 mRNA levels were 2.1 and 6.0 fold
higher than the control when treated with 10 and 50 mM CA, re-
spectively. DMCA treatment resulted in a milder effect of 1.5 and
2.9 fold expression compared to the control at 10 and 50 mM, re-
spectively. Again, HCA had no effect on Nrf2 mRNA levels (Fig. 3a).
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10 mM of CA treatment in A2780 cells. Higher concentrations in-
duced only 2.5 fold overexpression. DMCA and HCA showed dose
response expression with maximum expression of 2.5 fold of the
control (Fig. 3b). In the resistant cells (Fig. 3f) the basal level was
3 fold higher than A2780 cells control and all the compounds,
regardless of their concentration, did not induce GSTP1 mRNA
expression levels nor down regulate them (Fig. 3b).
GSR1 mRNA levels showed no signiﬁcant changes in the sen-
sitive cells following treatments with the three compounds.
However, in the resistant cells, CA induced 1.8 and 7.8-fold over-
expression at 10 and 50 mM, respectively. No other compound in-
duced any change in GSR1 expression (Fig. 3c). Notably, at high
concentration (100 mM), the mRNA levels of most genes tested
were as the basal levels or even lower indicating a bell-shaped
behavior.
No changes in GCLM expression were observed in the sensitive
cell line following the various treatments. CA treatment of 10 and
50 mM resulted in a 3.3 and 13.9-fold expression of GCLM mRNA in
the resistant cells (Fig. 3d). DMCA at same concentrations resulted
in 1.9 and 2.5-fold expression, and HCA had no effect on GCLM
mRNA levels.
HO-1 demonstrated the most signiﬁcant enhancement in
mRNA induction following the various treatments. As shown in
Fig. 3e, treatment with CA in different concentrations 10, 50 and
100 mM resulted in 7.1, 9.1 and 10.8-fold expression mRNA.a
c
Fig. 4. Inhibition of Nrf2 and phase II genes induction by trigonelline in A2780 and A2780
6 h and mRNA levels were measured by qRT-PCR. (a) Nrf2 mRNA levels after CA and/or t
(b) GSTP1mRNA levels after CA and/or trigonelline treatments for 6 h in A2780 cells (blac
treatments for 6 h in A2780 cells (black) and in A2780cisR cells (white). n¼3; data repHowever, in the resistant cells, CA induced HO-1 only by 1.6 fold of
the control at 100 mM. DMCA, which did not demonstrate any in-
duction in the sensitive cells, induced HO-1 by 1.5 and 1.6 fold at
50 and 100 mm, respectively. A signiﬁcant, 2.0-fold expression was
observed for 100 mM of HCA.
Effect of Nrf2 import inhibitor, trigonelline, on CA action
To validate the results from the Nrf2 translocation experiment,
we measured the mRNA levels of Nrf2, GSTP1 and HO-1 at the
same conditions as mentioned above with and without trigonel-
line. CA increased Nrf2 level by 2 and 4.5 fold in A2780 and
A2780cisR, respectively. Trigonelline alone had no effect on Nrf2
levels in A2780 cell but reduced Nrf2 by 2 fold in A2780cisR cells
(resistant cells). The combination of both, the same as in trigo-
nelline treatment, completely abolished the effect of CA (Fig. 4a).
Trigonelline demonstrated similar effects on GSTP1 mRNA levels.
In A2780 (sensitive cells) it had no effect on its own but in com-
bination with CA GSTP1 mRNA remained at the basal level. In
A2780cisR (resistant) trigonelline reduced the relatively high basal
levels of GSTP1 mRNA levels by 36%. Similar results were obtained
when CA and trigonelline were administrated together (Fig. 4b).
HO-1 mRNA levels were not affected in A2780cisR cells. How-
ever, in the sensitive cells HO-1 mRNA levels were highly induced
by CA (up to 9 fold of the control). Co-administration of CA with
trigonelline diminished the induction by 34% (Fig. 4c).b
cisR cells. Cells were treated with 50 mM CA, 1 mM trig or in combination of both for
rigonelline treatments for 6 h in A2780 cells (black) and in A2780cisR cells (white);
k) and in A2780cisR cells (white); (c) HO-1mRNA levels after CA and/or trigonelline
resented as mean7SD. npo0.05.
a b
Fig. 5. Glutathione-S-transferase (GST), glutathione reductase (GSR) and glutamate–cysteine ligase-modiﬁer subunit(GCLM) protein levels in A2780 and A2780cisR cell
following CA treatment for 16 h representative western blots of GST, GCLM and GSR (a) and quantiﬁcation (b). β Tubulin was used as loading control. Results expressed as fold
of control (sensitive cells) of 3 independent experiments.
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Western blot analysis of GST3/GSTP in A2780 cells showed a trend
of dose–response behavior following CA treatment, although nota
c
Fig. 6. Glutathione-S-transferase (GST), glutathione reductase-1 (GSR) and glutamate–c
(a) Enzymes activities in A2780 cells. (b) Enzymes activities in A2780cisR cells and (c) in
experiments each conducted in triplicate. npo0.05 comparing untreated cells.statistically signiﬁcant. CA increased GST levels by 40% and 60% at 10
and 100 mM, respectively. Similar to the ﬁndings of mRNA levels, the
protein levels of GST in A2780cisR cells were higher (25–30%) than in
A2780 cells. In those cells no further induction was evident.b
ysteine ligase (GCL) activities in A2780 and A2780cisR cell following CA treatment.
vitro enzymes activities. Data are expressed as % of control7SD of 3 independent
Table 1
ROS levels in A2780/cisR cells after CA, HCA and DMCA treatments normalized to control.
A2780 A2780cisR
10 lM 50 lM 100 lM 10 lM 50 lM 100 lM
CA 94.179.5 93.474.0 89.074.0 97.4712.2 94.074.2 88.372.4
DMCA 94.178.0 94.675.3 91.673.3 94.374.8 97.375.7 92.076.1
HCA 89.472.9 88.272.6 88.073.0 89.474.2 90.771.3 86.774.4
tBHPa 312.177.0 301.279.1
a tBHP¼tert-butylhydroperoxide.
R. Sirota et al. / Redox Biology 4 (2015) 48–59 55CA had no effect on GSR levels in A2780 cells, but showed a
bell-shaped response in the resistant cells with a maximum in-
crease of 20% at 50 mM.
GCLM was elevated by 15% and 30% at 10 and 100 mM, re-
spectively, in A2780 cells. Again in the resistant cells the levels
were higher in untreated cells (by 25%) and were unchanged fol-
lowing CA treatments.
It is noteworthy that GST and GSR protein translation were in
correlation with their mRNA levels following CA treatments.a
c
Fig. 7. Phase II genes expression in A2780 cells after CA and DMCA treatment in the prese
the same treatments in presence of 300 U of catalase in cell media (white); (b) GSTP1 m
presence of 300 U of catalase in cell media (white); (c) HO-1mRNA levels after CA and DM
in cell media (white); n¼3; data represented as mean7SD.However, such correlation was not observed for GCLM protein.Phase II enzymes activities following CA treatment
In order to induce phase II enzymes and evaluate their activity,
the cells were treated with CA, the most potent Nrf2/Keap1
pathway inducer. The activities were normalized to the control (no
treatment) of the two cell lines.b
nce of catalase. (a) Nrf2 mRNA levels after CA and DMCA 6 h treatments (black) and
RNA levels after CA and DMCA 6 h treatments (black) and the same treatments in
CA 6 h treatments (black) and the same treatments in presence of 300 U of catalase
Fig. 8. Nrf2 and GSTP1 expression in A2780 cells after CA and DMCA treatments
under normal growth condition and in the absence of oxygen. Nrf2 (black) and
GSTP1 (white) mRNA levels after CA and DMCA treatments for 6 h. n¼4; data
represented as mean7SD. npo0.05 comparing untreated cells.
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monstrated a bell-shaped curve. The maximum enzyme activity
(250% vs. control) was observed at 50 mM concentration of CA. At
100 mM (Fig. 6a), the activity signiﬁcantly decreased towards the
base line. Surprisingly, when the resistant cells were treated with
CA, an opposite bell shape was observed. At 50 mM CA the activity
of the enzyme decreased signiﬁcantly (50% of control) and re-
turned to baseline at 100 mM treatment (Fig. 6b).
The activity of GSR1 following treatment with various con-
centrations of CA was decreased to 40–50% of the control in the
sensitive cells (A2780, Fig. 6a). No effect on GSR1 activity was
detected in the resistant cells (Fig. 6b).
The activity of GCL in the sensitive line was increased slightly
by 20% at 10 and 50 mM of CA treatment and further by 50% at
treatment of 100 mM (Fig. 6a). A moderate increase (40%) was
observed in the resistant cells only following treatment of cells
with CA at 100 mM (Fig. 6b).
In vitro activity assays of the three enzymes show that CA in-
hibits the activity of GST and GSR with IC50 of 95 and 70 mM, re-
spectively (Fig. 6c).
Cellular oxidative stress following CA, HCA and DMCA
Polyphenols undergo oxidation to form semiquinones or qui-
nones and subsequently produce H2O2. As Nrf2/Keap1 system
possesses oxidative stress sensor activities, it is possible that the
observed Nrf2 activation might be due to the production of re-
active oxygen species (ROS) (e.g. hydrogen peroxide) and not due
to the polyphenol per se. ROS formation was measured in the
treated cells (following 6 h of incubation) by H2DCFDA/DCF
method [39]. The results in Table 1 show that none of the 3 com-
pounds increased the ROS levels compared to the control. It was
even suggested that ROS levels were reduced by 13% at 100 mM of
the various compounds although the changes are not statistically
signiﬁcant. tBHP, a positive control, at 50 mM elevated ROS levels
by 3 fold of the control.
Nrf2 and phase II genes expression in H2O2 and O2 free environments
While no evidence for increasing ROS levels was detected, the
involvement of low efﬂux of hydrogen peroxides and other ROS
produced by CA in low concentrations in cell culture media cannot
be disregarded as shown previously by Halliwell [40].To explore the role of ROS generated by CA outside the cells (CA
barely penetrated the cells, but did as other polyphenols and
bound to the outer membrane [41,42]) and its effect on Nrf2
pathway induction, we conducted two experiments.
1. Catalase (300U) was added to cell media and 2. The cells
were treated under anoxic conditions.
The addition of catalase to A2780 cell media had no effect on
the activation of the Nrf2 pathway by DMCA. However, it reduced
the induction of the Nrf2 induced by CA by 30% (Fig. 7a). Similar
results were observed for GSTP1and HO-1 (Figs. 7b and 6c
respectively).
Nrf2 mRNA levels remained unchanged following 6 h incuba-
tion of the cells with DMCA in an anoxic chamber. However, the
ability of CA to induce Nrf2 was reduced in anoxic environments
compared to normoxia conditions.
The results were similar to the results obtained in the catalase
experiments (sensitive cells) (Fig. 8). In these cells GSTP1 was in-
duced under anoxic condition by 3.5 fold, CA treatment under
these conditions had no further effect on GSTP1 levels.Discussion
Coffee has been found to be cancer preventive for many cancer
types. This phenomenon was attributed to the antioxidant
scavenging properties of coffee polyphenols but can be also at-
tributed to Nrf2 induction by these compounds. Nrf2/Keap1 is a
hormetic pathway, in which low doses of inducers may lead to
susceptibility for ROS accumulation and oxidative stress. However,
sustained or high dosage of inducers might lead to drug resistance
and give advantage to cancerous cells in their microenvironment.
However, a transient induction by polyphenols (or other inducers)
will lead to an increase in phase II enzymes and therefore may
prevent diseases including cancer [43]. It is now established that
Nrf2 and inducible phase II genes play an important role in cancer
development, progression and sensitivity to chemotherapeutic
treatments.
We found that caffeic acid, a coffee polyphenol, is capable of
inducing the Nrf2 pathway in A2780and A2780cisR cells. We
suggested that although caffeic acid possesses reducing properties
(due to its phenolic group) it can act as an electrophile as well. The
double bond in its structure (Fig. 1) might act as a Michael ac-
ceptor and attract electrons. Moreover, caffeic acid can be oxidized
to the quinone form, which can act also as an electrophile directly
or indirectly. These electrophilic properties may lead to the acti-
vation of the Nrf2/Keap1 pathway due to oxidation of the thiol
groups on the Keap1 protein. These ﬁndings encouraged us to
explore the mechanism by which CA induces Nrf2 and subse-
quently phase II enzymes.
In order to determine the speciﬁc moieties responsible for the
induction of phase II enzymes a structure–activity relationship of
caffeic acid was conducted. It was also of interest to determine
whether CA can evoke such cancer protection mechanisms in
cancer cells sensitive to chemotherapeutic compounds and cells
which are resistant to such treatment. Therefore, 2 cell lines were
chosen: A2780 cell (sensitive to cisplatin treatment) and
A2780cisR cells (resistant to treatment). We also speculated that
caffeic acid which barely penetrates the cells, may act indirectly by
producing hydrogen peroxide outside the cells which in turn pe-
netrates and evokes the Nrf2/Keap1 response.
Immunocytochemical staining of Nrf2 in A2780 cell showed
that CA led to translocation of Nrf2 to the nucleus (Fig. 2). This
effect was completely abolished by co-treatment with trigonelline,
an inhibitor of Nrf2 translocation [38]. Trigonelline also inhibited
the mRNA expression of Nrf2, GSTP1 and HO-1 conﬁrming that
those genes are under the control of Nrf2 pathway.
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itiation of the Nrf2 pathway and the translocation of Nrf2 into the
nucleus, three different molecules were studied; CA (double bond
and phenolic groups), DMCA (without the phenolic groups), and
HCA (without the double bond). It can be concluded that the Mi-
chael acceptor moiety (the double bond) is necessary for Nrf2/
Keap1 and subsequently phase II gene induction (Fig. 3). Catechol
group alone possess reducing properties and therefore, it was not
expected that this compound would initiate the Nrf2 pathway.
Surprisingly, it has been found that the combination of both
groups (phenolic and double bond) acted synergistically to acti-
vate the Nrf2 response (CA vs. DMCA).
Nrf2 mRNA basal levels found to be twice as high in the re-
sistant cells than in the sensitive ones, in agreement with Bao et al.
[44]. In these cells Nrf2 was also much more inducible, especially
by CA, with an increase of 6 fold. This ﬁnding may suggest that
resistant cells are intrinsically more capable of dealing with
stressors. The strong induction of Nrf2 and subsequently the
protecting phase II enzymes may provide these cells with the
ability, at least partly, to overcome cisplatin cytotoxicity. Lister
et al. demonstrated that Nfr2 is 10-fold overexpressed in pan-
creatic cancer cells than in normal pancreatic ductal cells [45].
Here we compared Nrf2 levels from two different lines of cancer
cells. It can be speculated that the differences in Nrf2 levels be-
tween cisplatin resistant cells and healthy ovarian cells may be
even more pronounced.
It has been suggested that one of the mechanisms of cellular
resistance towards cisplatin is detoxiﬁcation of the drug by GSH
adduction which could be facilitated by the GSTs enzymes. Even
though cisplatin–GSH adducts found in in vitro experiments and
were separated fromwhole cells, it has also been found that GSTPs
are very slow catalysts of these reactions [46]. The authors con-
cluded that GST is too slow to produce cisplatin–GSH adducts in
living cells. Nevertheless, a correlation was found between GST
levels and susceptibility to cisplatin resistance in cancer patients
[47].
In the present work we showed that there is a 3-fold increase
in the basal levels of GSTP1 in the resistant line vs. the sensitive
cells. It should be noted that the pattern of induction of the gene
between the 2 cell lines is different. While there was no further
induction in the resistant cells, in the sensitive cells, CA and DMCA
induced GSTP1 to the same level as the basal level of resistant cells.
Same pattern was observed at the protein level.
It seems that GSTP1 reaches a certain saturation which limits its
further induction and may be high enough to provide protection.
Recently, GSTs were linked to two noncatalytic pathways critical to
cell survival. GST involved in S-glutathionylation of key proteins,
including self S-glutathionylation, is an inhibitor of JNK signaling
pathway [48]. It can be speculated that a tight regulation on GST
levels is preserved because GSTs enzymes are a multi-functional
family controlling not only cell detoxiﬁcation but also key survival
factors.
GSR1 recycles oxidized GSH in the cells. GSR1 basal mRNA and
protein levels in both cell lines were found to be equal. The sen-
sitive cells were unresponsive to induction at all concentrations of
CA unlike the resistant cells in which 50 mM CA induced a 6-fold
overexpression. Hirano et al., found that overexpression of ribo-
ﬂavin kinase which is involved in the ﬁrst step in the FAD synth-
esis (FAD is an essential co enzyme for GSR) renders cell resistance
not only to cisplatin but also to hydrogen peroxide [49]. Cisplatin
induces oxidative stress and hydrogen peroxide production in cells
and is believed to be one of the mechanisms underlying cisplatin-
induced nephrotoxicity. The results suggest that the sensitive cells
are not as adaptive to oxidative stress as the resistant cells and
thus are more susceptible to hydrogen peroxide induced apoptosis
(data not shown).A different pattern of RNA induction by CA was observed for
HO-1. In contrast to the previous results indicating signiﬁcant in-
duction of the various phase II enzymes' mRNA in the resistant
cells, only a 2-fold increase was observed for HO-1 at high con-
centrations of CA and DMCA as shown in Fig. 3e. However, when
the sensitive cells were treated with CA, a 10-fold increase in HO-1
mRNA levels in a dose dependent manner was recorded. HO-1
facilitates the catabolism of heme to CO, ferrous iron and biliverdin
which are consequently reduced by biliverdin reductase to bilir-
ubin, each of which acts via distinct molecular targets to inﬂuence
cell function as proliferation, apoptosis and coping with oxidative
stress. Many studies have shown that HO-1 induction attenuates
cisplatin-induced nephrotoxicity [50] and ototoxicity via the re-
duction of oxidative stress [51,52]. The results obtained for HO-1
are paradoxical since HO-1 was highly overexpressed in cisplatin
sensitive cells following CA treatment but not in resistant cells.
Thus, induced overexpression of HO-1 might be positive in the
reduction of cisplatin side effects but not necessarily lead to re-
sistance towards the drug.
Although we demonstrated the necessity of the double bond
(Michael acceptor) in CA molecule to induce the Nrf2/Keap1
pathway, the mechanism by which the phenolic groups contribute
to this induction (see previous section, the combination of both
groups, phenolic and double bond, acted synergistically to activate
the Nrf2 response) was elucidated. Therefore, the possibility that
CA can produce ROS in the cell interior (H2O2 for example) which
in turn can activate the Nrf2/Keap1 pathway was studied.
The results obtained from the DCF experiments did not indicate
an enhanced production of ROS inside the cells by the three CA
derivatives studied. However, using this methodology may not be
sensitive enough to detect minor changes in ROS levels. Therefore,
the possibility that CA bound to a cell's outer membrane can un-
dergo autoxidation and produce hydrogen peroxide in small
quantities which in turn can diffuse into the cell and evoke the
Nrf2/Keap1 response was investigated. Therefore, catalase, which
cannot penetrate into the cells, was added to remove hydrogen
peroxide in cell surroundings. The result showed attenuation of
Nrf2 induction by CA by 40% indicating the involvement of exo-
genous hydrogen peroxide. The fact that DMCA, which does not
contain phenolic groups and cannot undergo autoxidation, was
not affected by the presence of catalase indicates that DMCA can
only activate the pathway via the double bond and supports the
assumption that CA can activate the Nrf2/Keap1 pathway by these
two mechanisms. Therefore, generated H2O2 plays an important
role in CA-mediated Nrf2 activation.
To further explore the importance of ROS produced extra-
cellularly or intracellularly in activation of the Nrf2/Keap1 path-
way, the cells were treated with CA under anoxic conditions. The
results show clearly that CA can induce Nrf2/Keap1 pathway in the
sensitive cells under these conditions indicating that the double
bond (Michael acceptor) alone is sufﬁcient to induce a response
and also suggests that CA, at least partially, can penetrate the cell.
The effect of CA and DMCA at low oxygen conditions was similar to
that observed when a catalase was used in the aerobic conditions.
As can be seen, although most genes are up-regulated by CA
and sequentially the proteins levels increased (Fig. 5), the enzyme
activity of some of the enzymes in the cells decreased comparing
to the control. The most dramatic effect was observed in the GSTP1
activity in A2780 (sensitive cells) compared to A2780cisR cells
(resistant cells). A possible explanation for the bell shaped activity
of GST in A2780 cells may be the competition between induction
and inhibition. Indeed, we found that CA inhibits GST and GSR
activity in vitro. This ﬁnding is in agreement with a previous work
of Ploemen et al. [53]. GSR1 activity in A2780 cells (in these cells
no increase in protein was observed) was inhibited by 50% but not
in the resistant cells in which the protein levels were increased.
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GSTP1 and GSR1 inducer and also as their inhibitor. This ﬁnding
may indicate that CA may be used as a potential chemotherapeutic
adjuvant due to its ability to rescue healthy cells from drug in-
duced oxidative stress and also, in the right concentration, prevent
the activity of GST and therefore, prevent the inactivation of che-
motherapeutics drugs.
In conclusion, the mechanism of induction of Nrf2 and phase II
enzymes by CA has been elucidated. The electrophilic moiety in CA is
essential for the oxidation of the Keap1 protein inside the cell. Al-
though, the nucleophilic moiety (the catechol/quinone) can provide
scavenging ability, it can also contribute to Nrf2/Keap1 activation via
production of hydrogen peroxide intracellularly or extracellularly.
In the cancer cells which are resistant to cisplatin, the basal
levels of some of the phase II enzymes are high and different from
control both in the gene and in the protein levels. In these cells CA
possesses a different pattern of induction. Finally, CA possesses a
dual activity, as initiator of the Nrf2/Keap1 pathway and as in-
hibitor of GSTP1.
Therefore, the effect of coffee on healthy subjects and cancer
patients may be different. The use of coffee in people under che-
motherapeutic treatment should be carefully examined since it
contains both Nrf2 inducers and an inhibitor.Conﬂict of interest
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